general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 


Physician Support
Radical Prostatectomy
   
     
 

Viadur is indicated in the palliative treatment of advanced prostate cancer. Bayer is not responsible for, and does not endorse, any of the information found on this page.

Treatment Options

Chemotherapy
  Cryosurgery
  Hormone therapy
  Radiation therapy
  Radical prostatectomy
  Transurethral resection of the prostate (TURP)
  Watchful waiting

There are many treatments for prostate cancer. The best one for you depends on a number of factors. These include your age, your overall health, and the stage and grade of your cancer.

Be sure to discuss the possible benefits, risks and side effects with each option. The sections here outline some of the general risks and side effects. However, your doctor is the best source of information on your condition. Before you and your doctor select any treatment approach, risks and benefits should be thoroughly discussed.Take the time to research all of your treatment options. Consider getting a second opinion before making a final decision. The most common treatment options for prostate cancer include watchful waiting, radiation, and hormone therapy.

Radical Prostatectomy

Radical prostatectomy removes the entire prostate gland, as well as some surrounding tissues and structures.1 Typically, this surgery is done if it appears the cancer has not spread outside the prostate.2 There are two basic types of radical surgery for removal of the prostate: radical retropubic prostatectomy and radical perineal prostatectomy.3 The only difference between these two types that is of importance to the patient is the surgeon uses different routes to reach the prostate.

In radical retropubic prostatectomy, the surgeon makes an incision down to the prostate through the lower abdomen.4 In a radical perineal prostatectomy, the surgeon makes an incision up to the prostate between the anus and the scrotum.5

What are possible side effects: Impotence (or the lack of penile erections), urinary incontinence (leaking of urine),6 bleeding during and after surgery, as well as the possibility of developing a bladder-neck contracture, deep venous thrombosis, pulmonary emboli, or a urinary-tract infection.7

Who makes a good candidate: Men who have prostate cancer that is believed to be confined to the prostate, who should be able to safely undergo an operation requiring general anesthesia, and who should have a life expectancy of at least seven to 10 years.8

Viadur is indicated in the palliative treatment of advanced prostate cancer.

 


Printer-Friendly Version


References

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).


Distributed and Marketed by:

Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.